Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection
<ol> <li>SARS-CoV-2 specific serum IgG (AU/ml), as measured by iFlash 1800 chemiluminescent immunoassay (YHLO, China), in 15 patients with severe COVID-19 and 32 patients with mild COVID-19 over >90 days follow-up post symptom onset.</li> <li>SARS-CoV-2 receptor binding domain specific serum IgM, IgG and IgA in samples collected >75 days post symtom onset from 21 patients with mild or severe COVID-19. Measured by in-house ELISA, results presented as AUC of titration curve.</li> </ol>
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 4
- Access
- 16
- Reuse readiness
- 0
- Engagement
- 0
Dataset details
- Repository
- zenodo
- Published
- July 6, 2020
- License
- cc-by-4.0
- DOI
- 10.5281/zenodo.3934336
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.